Back to top

Image: Bigstock

Zacks.com featured highlights include Phibro Animal Health, Argan and Ubiquiti

Read MoreHide Full Article

For Immediate Release

Chicago, IL – December 4, 2025 – Stocks in this week’s article are Phibro Animal Health Corp. (PAHC - Free Report) , Argan, Inc. (AGX - Free Report) and Ubiquiti Inc. (UI - Free Report) .

3 Momentum Anomaly Stocks to Buy as Markets Gear Up for 2025 End

The broader U.S. equity markets witnessed a roller coaster ride over the past few days as a five-day winning streak was punctured on Monday due to falling cryptocurrencies, only to rise again as Bitcoin regained its lost sheen. The sharp pullback in Bitcoin, the flagship cryptocurrency, led to intense market volatility as the digital currency struggled to stay above the benchmark $90,000 tally.

To add to the woes, concerns regarding the increasing valuation of AI firms remain an overhang. Industry experts widely expect that growth in AI firms would not be commensurate with hefty investments, leading to a market correction in the near term. However, the odds of the Federal Reserve lowering its benchmark borrowing rate at its final meeting of the year this month had greatly increased, with markets pricing a roughly 89% chance of a rate cut.

Amid the vagaries of the market, investors often seek to employ time-tested winning strategies to fetch sustained profits. One of the most successful game plans to beat the blues is to bet on momentum stocks, like Phibro Animal Health Corp., Argan, Inc. and Ubiquiti Inc. when value or growth investing fails to generate the desired profits.

This approach primarily tends to follow the adage, "the trend is your friend." At its core, momentum investing is "buying high and selling higher." It is based on the idea that once a stock establishes a trend, it is more likely to continue in that direction because of the momentum that is already behind it. Momentum investing is a way to profit from the general human tendency to extrapolate current trends into the future. It is based on that gap in time before the mean reversion occurs, i.e., before prices become rational again.

Momentum strategies have been known to be alpha-generative over a long period and across market stages. Therefore, this strategy is quite tricky to implement, as detecting these trends is no child's play. Here, we have created a strategy to help investors get in on these fast movers and rake in handsome gains. Our screen will help you benefit from long-term price momentum and a short-term pullback in price.

Here are three of the six stocks that made it through this screen:

Headquartered in New Jersey, Phibro is a leading global diversified animal health and mineral nutrition company. It provides a broad range of products for food animals, including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries.

The stock has surged 74.9% in the past year but declined 8.2% in the past week. Phibro has a Momentum Score of B.

Headquartered in Arlington, VA, Argan provides a full range of construction and related services to the power industry, including engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services in the United States, the Republic of Ireland and the United Kingdom. It offers services through its Gemma Power Systems and Atlantic Projects Company operations.

The stock has jumped 138.5% in the past year but declined 4.2% in the past week. Argan has a Momentum Score of A.

Headquartered in New York, Ubiquiti offers a comprehensive portfolio of networking products and solutions for service providers and enterprises. Its service-provider product platforms offer carrier-class network infrastructure for fixed wireless broadband, wireless backhaul systems and routing; while enterprise product platforms provide wireless local area network infrastructure, video surveillance products and machine-to-machine communication components.

The stock has soared 56.6% in the past year but lost 2% in the past week. Ubiquiti has a Momentum Score of A.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2798811/3-momentum-anomaly-stocks-to-buy-as-markets-gear-up-for-2025-swansong

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://www.twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Argan, Inc. (AGX) - free report >>

Phibro Animal Health Corporation (PAHC) - free report >>

Ubiquiti Inc. (UI) - free report >>

Published in